Mahajan, U. V., Parker, J. J., Williams, N. R., Bhati, M. T., Ku, S., Grant, G., … Halpern, C. H. (2020). Adjunctive repetitive transcranial magnetic stimulation delivers superior quality of life for focal epilepsy compared to anti-epileptic drugs: A meta-analytic utility prediction study. Brain Stimul, 13(2), 430–432. https://doi.org/10.1016/j.brs.2019.12.006

Mahajan, Uma V., Jonathon J. Parker, Nolan R. Williams, Mahendra T. Bhati, Seul Ku, Gerald Grant, Robert S. Fisher, Sherman C. Stein, and Casey H. Halpern. “Adjunctive repetitive transcranial magnetic stimulation delivers superior quality of life for focal epilepsy compared to anti-epileptic drugs: A meta-analytic utility prediction study.” Brain Stimul 13, no. 2 (2020): 430–32. https://doi.org/10.1016/j.brs.2019.12.006.

Mahajan UV, Parker JJ, Williams NR, Bhati MT, Ku S, Grant G, et al. Adjunctive repetitive transcranial magnetic stimulation delivers superior quality of life for focal epilepsy compared to anti-epileptic drugs: A meta-analytic utility prediction study. Brain Stimul. 2020;13(2):430–2.

Mahajan, Uma V., et al. “Adjunctive repetitive transcranial magnetic stimulation delivers superior quality of life for focal epilepsy compared to anti-epileptic drugs: A meta-analytic utility prediction study.” Brain Stimul, vol. 13, no. 2, 2020, pp. 430–32. Pubmed, doi:10.1016/j.brs.2019.12.006.

Mahajan UV, Parker JJ, Williams NR, Bhati MT, Ku S, Grant G, Fisher RS, Stein SC, Halpern CH. Adjunctive repetitive transcranial magnetic stimulation delivers superior quality of life for focal epilepsy compared to anti-epileptic drugs: A meta-analytic utility prediction study. Brain Stimul. 2020;13(2):430–432.